Press release
Single-Use Bioreactor Market to Reach USD 15.66B by 2035
The Single-Use Bioreactor Market has emerged as one of the most transformative segments within bioprocessing and biomanufacturing. As biopharmaceutical companies race to develop complex biologics, vaccines, cell and gene therapies, and recombinant proteins, traditional stainless-steel bioreactors are increasingly being replaced-or complemented-by flexible, scalable, and contamination-resistant single-use systems.
In 2025, the global single-use bioreactor market was valued at USD 3.52 Billion. Supported by strong adoption across pharmaceutical and biopharmaceutical manufacturing, the market is projected to grow at a CAGR of 16.10% from 2026 to 2035, reaching an estimated USD 15.66 Billion by 2035. This growth reflects not only technological progress but also a strategic shift in how biologics are produced, scaled, and commercialized.
Get a Free Sample Report with Table of Contents - https://www.expertmarketresearch.com/reports/single-use-bioreactor-market/requestsample.
Understanding Single-Use Bioreactors in Modern Biomanufacturing
Single-use bioreactors (SUBs) are disposable systems typically composed of pre-sterilized plastic bags integrated with mixing, aeration, and monitoring components. Unlike conventional bioreactors, they eliminate the need for cleaning, sterilization, and validation between batches.
Key characteristics that define single-use bioreactors include:
Pre-sterilized and ready-to-use designs
Reduced risk of cross-contamination
Faster setup and turnaround times
Lower capital expenditure compared to stainless steel systems
Enhanced flexibility for multiproduct facilities
From an operational perspective, these systems align well with today's demand for agile manufacturing, smaller batch sizes, and accelerated time-to-market.
Single-Use Bioreactor Market Size and Forecast Outlook
The growth trajectory of the Single-Use Bioreactor Market is underpinned by structural changes in the biopharmaceutical industry. Increasing investment in biologics, biosimilars, and advanced therapies has expanded the addressable market for flexible bioprocessing solutions.
Key market indicators include:
Market value in 2025: USD 3.52 Billion
Forecast value by 2035: USD 15.66 Billion
Forecast CAGR (2026-2035): 16.10%
This strong double-digit growth reflects rising demand from both large biopharma manufacturers and smaller biotech firms that prefer modular, scalable production models.
Why Single-Use Bioreactors Are Gaining Industry Preference
The increasing popularity of single-use systems is not accidental. Manufacturers across the globe cite several practical advantages that make these systems indispensable.
Major benefits driving adoption include:
Operational efficiency: Reduced downtime between production runs
Cost optimization: Lower upfront capital and maintenance costs
Scalability: Easy scale-up and scale-down for clinical and commercial production
Regulatory compliance: Simplified validation and reduced cleaning documentation
Sustainability trade-offs: Less water and chemical usage despite higher plastic waste
These advantages are particularly valuable in environments where speed, flexibility, and compliance are critical.
Market Segmentation by Product Type
Single-Use Bioreactor Systems
Single-use bioreactor systems represent the largest revenue share within the market. These integrated solutions combine disposable bags, sensors, controllers, and mixing mechanisms into a unified platform.
They are widely used in:
Upstream processing
Cell culture expansion
Pilot-scale and commercial manufacturing
Their dominance is driven by ease of use and compatibility with diverse cell lines.
Media Bags
Media bags play a crucial supporting role in bioprocessing workflows. They are used for the storage, mixing, and transfer of culture media and buffers.
Key adoption drivers include:
Reduced contamination risks
Compatibility with closed-system processing
Cost-effective handling of large media volumes
Filtration Assemblies and Other Components
Filtration assemblies and related disposable components support clarification, separation, and purification processes. Their demand is growing as manufacturers aim to build fully single-use upstream and downstream workflows.
Read the Full Report with the Table of Contents - https://www.expertmarketresearch.com/reports/single-use-bioreactor-market.
Market Segmentation by Cell Type
Mammalian Cells
Mammalian cell cultures account for the largest share of the Single-Use Bioreactor Market. These cells are essential for producing monoclonal antibodies, vaccines, and complex recombinant proteins.
Their sensitivity to contamination and process variability makes single-use systems especially suitable.
Bacteria and Yeast
Single-use bioreactors are also gaining traction in bacterial and yeast-based processes, particularly in recombinant protein production and enzyme manufacturing.
Benefits in these applications include:
Rapid turnaround times
Reduced cleaning requirements
Improved containment
Other Cell Types
Emerging applications involving insect cells and plant-based expression systems are expanding the versatility of single-use technologies.
Market Segmentation by Molecule Type
Monoclonal Antibodies
Monoclonal antibodies remain the largest molecule segment driving the market. Single-use bioreactors enable efficient clinical-to-commercial transitions in antibody production.
Vaccines
The global push for rapid vaccine development has significantly boosted demand for disposable bioreactors. Their ability to support fast scale-up was clearly demonstrated during recent global health emergencies.
Stem Cells and Recombinant Proteins
Cell and gene therapy manufacturing relies heavily on closed, contamination-free systems. Single-use bioreactors are increasingly used for:
Stem cell expansion
Viral vector production
Recombinant protein expression
Market Segmentation by End Use
Pharmaceutical and Biopharmaceutical Industries
Pharmaceutical and biopharmaceutical companies account for the largest share of market demand. These organizations benefit from:
Reduced capital investment
Faster product development cycles
Compliance with global regulatory standards
Contract Research Organizations (CROs)
CROs increasingly rely on single-use systems to support multiple clients and projects simultaneously. The flexibility of these systems aligns well with contract-based manufacturing models.
Other End Users
Academic institutions and research laboratories also contribute to demand, particularly in early-stage development and translational research.
Regional Insights into the Single-Use Bioreactor Market
North America
North America dominates the global market due to strong biopharmaceutical infrastructure, high R&D spending, and early adoption of advanced manufacturing technologies.
Europe
Europe follows closely, supported by government funding for biologics, growing biosimilar production, and strong regulatory frameworks encouraging innovation.
Asia Pacific
Asia Pacific is expected to witness the fastest growth during the forecast period. Factors driving this trend include:
Expansion of biomanufacturing capacity
Rising investments in China, India, and South Korea
Growing presence of contract manufacturing organizations
Latin America, Middle East, and Africa
These regions are gradually adopting single-use technologies as healthcare infrastructure improves and local biologics production increases.
Competitive Landscape and Key Market Players
The Single-Use Bioreactor Market is moderately consolidated, with established life science companies leading innovation and capacity expansion.
Prominent companies include:
Sartorius AG - A global leader in single-use bioprocessing solutions
Cytiva - Known for scalable bioreactor platforms and integrated workflows
Merck KGaA - Strong presence in disposable technologies and process analytics
Eppendorf SE - Focuses on precision bioprocessing solutions
Pall Corporation - Specializes in filtration and single-use assemblies
These players compete on technology innovation, scalability, regulatory compliance, and global service capabilities.
Challenges Facing the Single-Use Bioreactor Market
Despite strong growth prospects, the market faces certain challenges:
Concerns about plastic waste and environmental sustainability
Limitations in large-scale commercial volumes compared to stainless steel systems
Supply chain disruptions affecting disposable component availability
However, ongoing R&D efforts aim to address these issues through recyclable materials and hybrid manufacturing models.
Future Outlook for the Single-Use Bioreactor Market
The future of the Single-Use Bioreactor Market is closely tied to the expansion of biologics, personalized medicine, and decentralized manufacturing. Innovations in sensor integration, automation, and digital monitoring are expected to further enhance system performance.
As regulatory agencies continue to support advanced manufacturing technologies, adoption is likely to deepen across both developed and emerging markets.
Discover More Reports
Dental Laboratories Market - https://bit.ly/3XDJUiI.
Energy Recovery Ventilator Market - https://bit.ly/4o1VcYY.
Emergency Escape Breathing Device Market - https://bit.ly/3X6PmdR.
Nootropics Market - https://bit.ly/4oNrHvd.
Media Contact
Company Name: Claight Corporation
Contact Person: Roshan Kumar, Business Consultant
Email: sales@expertmarketresearch.com
Toll-Free Number: US +1-415-325-5166 | UK +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA
Website: www.expertmarketresearch.com
About Us
Acquire unparalleled access to critical industry insights with our comprehensive market research reports, meticulously prepared by a team of seasoned experts. These reports are designed to equip decision-makers with an in-depth understanding of prevailing market trends, competitive landscapes, and growth opportunities.
Our high-quality, data-driven analysis provides the essential framework for organizations seeking to make informed and strategic decisions in an increasingly complex and rapidly evolving business environment. By investing in our market research reports, you can ensure your organization remains agile, proactive, and poised for success in today's competitive market.
Don't miss the opportunity to elevate your business intelligence and strengthen your strategic planning. Secure your organization's future success by acquiring one of our Expert Market Research reports today.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Single-Use Bioreactor Market to Reach USD 15.66B by 2035 here
News-ID: 4315151 • Views: …
More Releases from Expert Market Research
Gene Therapy Market Grows at 22.8% CAGR to 2035
How Is the Gene Therapy Market Shaping the Future of Personalized Medicine?
The Gene Therapy Market is at the forefront of revolutionizing modern medicine, offering the promise of treating and in some cases curing, previously untreatable genetic disorders. Gene therapy uses DNA or RNA-based vectors to correct or replace defective genes, targeting the root cause of diseases rather than managing symptoms. This approach is transforming patient care in areas like oncology,…
Epigenetics Market to Reach USD 5.33B by 2035
How Is the Epigenetics Market Transforming the Future of Precision Medicine and Disease Research?
The Epigenetics Market has emerged as one of the most dynamic and transformative segments of the global life sciences industry. By focusing on heritable changes in gene expression that do not alter the DNA sequence, epigenetics is reshaping how researchers and clinicians understand disease mechanisms, drug responses, and personalized medicine. From cancer research to developmental biology and…
3D Neuroscience Market Expands at 15.2% CAGR
How Is the 3D Neuroscience Market Revolutionizing Brain Research and Clinical Decision-Making?
The 3D Neuroscience Market is redefining how scientists, clinicians, and healthcare systems understand the human brain. By enabling high-resolution, three-dimensional visualization and functional mapping of neural structures, 3D neuroscience technologies are unlocking deeper insights into neurological disorders, cognitive function, and brain connectivity. As brain-related diseases rise globally and precision medicine gains momentum, 3D neuroscience has moved from a niche…
Global Fertility Test Market to Hit USD 1.31B by 2035
Can the Fertility Test Market Redefine Early Family Planning in a World Facing Rising Infertility?
The Fertility Test Market has emerged as a critical segment of the global reproductive health ecosystem, addressing one of the most pressing healthcare and social challenges of our time-infertility. As more individuals and couples seek early insights into their reproductive health, fertility testing solutions are becoming an essential first step in family planning, clinical decision-making, and…
More Releases for Bioreactor
Water Pollution Surge Spurs Growth In The Membrane Bioreactor Market: An Emergin …
The Membrane Bioreactor Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Projected Growth of the Membrane Bioreactor Market?
The market size for membrane bioreactors has experienced swift expansion in the last few years. The forecast predicts an escalation from $4.24 billion in 2024…
Technological Innovations Propel The Membrane Bioreactor Market Forward Trend: A …
What industry-specific factors are fueling the growth of the membrane bioreactor market?
The escalation in water contamination levels is playing a substantial role in propelling the membrane bioreactor market's expansion. The phenomenon of water pollution is characterized by the release of harmful chemicals or organisms into bodies of water such as rivers, lakes, and seas. Such instances of water pollution sprout from the lack of clean, potable water. Amidst the surge…
Cellbag Bioreactor Chambers Market - Seamless Cell Culturing: Cellbag Bioreactor …
Newark, New Castle, USA: The "Cellbag Bioreactor Chambers Market" provides a value chain analysis of revenue for the anticipated period from 2023 to 2031. The report will include a full and comprehensive analysis of the business operations of all market leaders in this industry, as well as their in-depth market research, historical market development, and information about their market competitors.
Cellbag Bioreactor Chambers Market: https://www.growthplusreports.com/report/cellbag-bioreactor-chambers-market/8938
This latest report researches the industry structure,…
Microbial Bioreactor Market
The Global Microbial Bioreactor Market is expected to grow at a CAGR of 20.1% during the forecasting period (2022-2029).
Micro bioreactors serve as a multitude of scale-down needs for bioprocesses based on mammalian cells. Microbioreactor technology has allowed for rapid advancements in biotechnology process development and investigation of various biological systems from industrial biotechnology and pharmaceutical biotechnology. Micro bioreactors range in complexity from simple micro-tier-based systems to complex automated parallel bioreactors…
Global Membrane Bioreactor Market - Forecasts to 2026
The findings reviewed by GME stated that the Global Membrane Bioreactor Market will expand with a CAGR value of 7.0 percent from 2021 to 2026. The Membrane Bioreactor (MBR) market will expand rapidly due to increased ecological concerns about wastewater management and dwindling freshwater resources., population growth, shifting consumer habits, global warming, urbanization, and industrialization.
Browse 159 Market Data Tables and 119 Figures spread through 189 Pages and in-depth TOC on…
Single Use Bioreactor Market Assessment 2017-2021
Single use bioreactors are witnessing rapid market growth due to increasing applications in production of antibodies, vaccines, recombinant proteins, growth factors and others. Single use bioreactors are not only used in pharmaceutical companies, but also in biotechnology research laboratories and contract manufacturing organizations. Single use bioreactors assure sterile conditions to quickly initiate production. This greatly reduced chances of cross contamination and increases productivity. Shorter turnaround time due to ease of…
